纳指生物科技ETF(513290)

动态评分: 5.70分

投资组合

报告日期 名称 比例
2024-06-30 Amphastar Pharmaceuticals Inc 0.2%
2024-06-30 Rocket Pharmaceuticals Inc 0.2%
2024-06-30 Beam Therapeutics Inc 0.2%
2024-06-30 Arvinas Holding Co LLC 0.19%
2024-06-30 NovoCure Ltd 0.19%
2024-06-30 Kymera Therapeutics Inc 0.19%
2024-06-30 Apogee Therapeutics Inc 0.18%
2024-06-30 Ardelyx Inc 0.18%
2024-06-30 Harmony Biosciences Holdings Inc 0.18%
2024-06-30 Syndax Pharmaceuticals Inc 0.18%
2024-06-30 诺瓦瓦克斯医药 0.18%
2024-06-30 Recursion Pharmaceuticals Inc-A 0.18%
2024-06-30 Mirum Pharmaceuticals Inc 0.17%
2024-06-30 Keros Therapeutics Inc 0.17%
2024-06-30 Edgewise Therapeutics Inc 0.17%
2024-06-30 Akero Therapeutics Inc 0.17%
2024-06-30 Veracyte Inc 0.17%
2024-06-30 Kura Oncology Inc 0.16%
2024-06-30 Ligand Pharmaceuticals Inc 0.16%
2024-06-30 Supernus Pharmaceuticals Inc 0.15%

投资模拟

公告&资料